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Abstract
Background: Osteoporosis affects over 200 million people worldwide, and represents a significant cost burden.
Although guidelines are available for best practice in osteoporosis, evidence indicates that patients are not
receiving appropriate diagnostic testing or treatment according to guidelines. The use of clinical decision support
systems (CDSSs) may be one solution because they can facilitate knowledge translation by providing high-quality
evidence at the point of care. Findings from a systematic review of osteoporosis interventions and consultation
with clinical and human factors engineering experts were used to develop a conceptual model of an osteoporosis
tool. We conducted a qualitative study of focus groups to better understand physicians’ perceptions of CDSSs and
to transform the conceptual osteoporosis tool into a functional prototype that can support clinical decision making
in osteoporosis disease management at the point of care.
Methods: The conceptual design of the osteoporosis tool was tested in 4 progressive focus groups with family
physicians and general internists. An iterative strategy was used to qualitatively explore the experiences of
physicians with CDSSs; and to find out what features, functions, and evidence should be included in a working
prototype. Focus groups were conducted using a semi-structured interview guide using an iterative process where
results of the first focus group informed changes to the questions for subsequent focus groups and to the
conceptual tool design. Transcripts were transcribed verbatim and analyzed using grounded theory methodology.
Results: Of the 3 broad categories of themes that were identified, major barriers related to the accuracy and
feasibility of extracting bone mineral density test results and medications from the risk assessment questionnaire;
using an electronic input device such as a Tablet PC in the waiting room; and the importance of including well-
balanced information in the patient education component of the osteoporosis tool. Suggestions for modifying the
tool included the addition of a percentile graph showing patients’ 10-year risk for osteoporosis or fractures, and
ensuring that the tool takes no more than 5 minutes to complete.
Conclusions: Focus group data revealed the facilitators and barriers to using the osteoporosis tool at the point of
care so that it can be optimized to aid physicians in their clinical decision making.
Background
Osteoporosis is a major public health concern, affecting
over 200 million people worldwide [1], an estimated
10 million in the US [2], 4 million in the UK [3], and
1.4 million in Canada [4,5]. Without effective osteoporo-
sis prevention and treatment, the burden of treating
fractures in Canada is projected to reach $32.5 billion
by the year 2018 [5,6], and $25.3 billion per year in the
US by the year 2025 [4]. This is further compounded by
the increasing proportion of people aged 65 and older,
which will likely lead to increased numbers of people
who will suffer from osteoporosis [6-8]. Fragility frac-
tures are the clinical consequence of osteoporosis, and
hip fractures have the most devastating prognosis [9,10],
as they can significantly impair quality of life, physical
function and social interaction, and can lead to admis-
sion to long-term care [10,11]. Although guidelines are
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dence indicates that patients are not receiving appropri-
ate diagnostic testing [15,16] or treatment [17]
according to guidelines. This evidence-to-care gap high-
lights the need for better knowledge translation (KT)
strategies [18]. The use of clinical decision support sys-
tems (CDSSs) may be one solution because they can
facilitate KT by providing high-quality evidence at the
point of care. CDSSs can also promote disease manage-
ment by generating patient-specific assessments or
recommendations for clinicians through the input of
patient data in a computer with a use of software algo-
rithms that can match pieces of information from a
knowledge database [19-22].
We conducted a systematic review of randomized con-
trolled trials (RCTs) to identify and describe the effec-
tiveness of tools that support clinical decision-making in
osteoporosis disease management [23]. Findings from
the review indicated that few osteoporosis CDSSs exist,
and most of the 13 included studies evaluating these
tools did not incorporate all 3 components of disease
management (i.e. risk assessment, diagnosis, and treat-
ment). However, interventions with multiple compo-
nents (e.g. those that include reminders and education)
and multiple targets (e.g. physicians and patients) appear
more promising for increasing appropriate bone mineral
density (BMD) testing and prescription of osteoporosis
medications such as bisphosphonates than single-com-
ponent or single-target interventions [23]. This is con-
sistent with a more recent study, which found that
compared with usual care, a multi-component interven-
tion targeted to family physicians and patients increased
BMD testing and prescription of osteoporosis medica-
tions in postmenopausal women with a wrist fracture
[24].
Findings from our systematic review also highlighted
the need to develop and rigorously evaluate an osteo-
porosis tool that can be used by physicians and patients
at the point of care. Currently, FRAX® is the only widely
available electronic tool that can be used to assess a
patient’s 10-year probability of a fracture http://www.
shef.ac.uk/FRAX[25]. However, this tool is not designed
to assess all aspects of osteoporosis disease manage-
ment; specifically, it does not provide customized, evi-
dence-based osteoporosis diagnosis and treatment
recommendations. We developed a conceptual model of
an osteoporosis tool using systematic review findings
and expert input from clinicians, information technolo-
gists and human factors engineers. The conceptual
model was designed to incorporate all 3 aspects of dis-
ease management (i.e. risk assessment, diagnosis, and
treatment), to target both physicians and patients, and
to include 3 components. The first component of the
osteoporosis tool is an electronic risk assessment
questionnaire (RAQ) consisting of questions to assess
osteoporosis risk as outlined by current practice guide-
lines [11]. The RAQ is designed so it can be completed
on a Tablet PC by eligible patients (men ≥ women ≥ 50
years of age) in a clinic waiting room (Please see
selected screen shots of the RAQ in Figure 1). Using a
decision algorithm programmed into the Tablet PC,
RAQ responses will then be processed, and two outputs
generated (one for the physician and one for the
patient), representing the second and third components
of the osteoporosis tool. The second component of the
tool is a paper-based, best practice recommendation
prompt (BestPROMPT), which is a one-page sheet sum-
marizing the patient’s RAQ responses, a section provid-
ing appropriate osteoporosis disease management
recommendations (e.g. to initiate bone mineral density
testing or osteoporosis medications such as bisphospho-
nates), and a graph to plot the patient’s1 0 - y e a rr i s kf o r
fractures. BestPROMPT was designed for physicians to
be used at the point of care (Figure 2). The third com-
ponent of the tool is a paper-based, customized osteo-
porosis educational (COPE) sheet, which outlines the
patient’s osteoporosis risks according to their RAQ
responses and osteoporosis information pertaining to
these identified risks. The COPE sheet can be given to
patients to take home at the end of their physician visit
(Figure 3). The objectives of the current study were to
qualitatively explore how physicians perceive the mean-
ing of CDSSs, the facilitators and barriers to using
CDSSs in their own practice; and to determine which
critical features, functions, and evidence are needed to
transform the conceptual model of the osteoporosis tool
into a functional prototype.
Methods
Design and sampling
We conducted a qualitative study of focus groups
between June and December 2007. The study was
approved by the University of Toronto Health Sciences
research ethics board. The sampling strategy for the
pilot focus group involved randomly selecting family
physicians, and specialists involved in the care of
patients with osteoporosis from a list of health care pro-
viders available from the CPSO (College of Physicians
and Surgeons of Ontario) database (representing 13,298
active family physicians and 3520 general internists). We
considered for inclusion all full-time physicians practi-
cing in the greater Toronto area who used any type of
patient record system. Of 406 faxed invitations, 8 parti-
cipants agreed to participate and 5 attended (3 family
physicians, 2 internists) the pilot focus group. Recruit-
ment involved sending invitations using a faxed letter,
which included a demographic questionnaire and con-
sent form. The demographic questionnaire included a
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(TPI) [26], which is a validated instrument used to mea-
sure participants’ baseline attitudes toward computers
and the Internet according to 3 reliable factors: Interest,
Approval, and Confidence [ 2 6 ] .T oa c h i e v ear i g o r o u s
qualitative methodology and saturation of themes
[27,28], we planned to recruit 5-8 participants per
focus group, and to stratify the sample to ensure
representation of participants from rural and urban set-
tings, and from university and non-university affiliated
sites. To increase our sample for subsequent focus
groups, we switched to a convenience sampling strategy
where we faxed invitations to the remaining 1324 physi-
cians representing the greater Toronto area, of which 9
family physicians and 2 internists attended 3 additional
focus groups.
Figure 1 Selected screen shots of the Risk Assessment Questionnaire (RAQ).
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An experienced moderator facilitated the discussion and
flow of the focus groups using a structured interview
g u i d e( s e ea d d i t i o n a lf i l e1 ) .T h ei n t e r v i e wg u i d ew a s
pilot tested with 2 family physicians and a general inter-
nist to ensure that they were clear and well understood.
Each focus group session lasted 1.5 hours and consisted
of 2 parts. Part 1 was devoted to generating discussion
about participants’ baseline understanding of CDSSs,
and to explore their perception of the facilitators and
barriers to using CDSSs in the context of their own
practice. We collected these baseline perceptions so that
participants could provide unbiased feedback about
CDSSs prior to being introduced to the conceptual
osteoporosis tool. In Part 2, participants provided com-
ments about the tool without any prompts from the
moderator.
Data collection and analysis
Focus group sessions were audiotaped and transcribed
verbatim. Data collection and quantitative content ana-
lyses were guided by the constant comparative method
of grounded theory methodology [27]. We used this
methodology because it facilitates the understanding of
a phenomenon that has not previously been studied (i.e.
the conceptual osteoporosis tool), and it enables the
exploration of the ways in which the “reality” of the tool
is socially constructed [29], particularly to clarify how
the tool might be used at the point of care in real prac-
tice settings.
Data was coded from transcripts using a process of
open, axial and selective coding [28,29] using NVivo 8
software (QSR International, 2008). Two investigators
(MK, CM) independently developed a coding scheme by
identifying, classifying, and labelling the primary pat-
terns in the content. During open coding, the constant
comparative approach was used to group the codes into
categories (where each category was considered as a
unit of analysis) and identified themes. Axial coding was
then applied to look at the inter-relationship of cate-
gories [29]. The frequency and consistency in which
participants indicated categories in the transcripts was
used to provide credibility to these categories. Inter-
coder reliability between the 2 investigators was assessed
using Kappa statistics (in NVivo 8), and any disagree-
ments (considered as < 90% agreement) were resolved
by consensus by a third investigator (SES).
Analysis involved a continuous iterative process,
whereby data from the pilot focus group were re-exam-
ined, and identified concepts were explored in the sub-
sequent focus groups. The analysis was thus cumulative
and iterative, with each focus group building on the dis-
cussions of the proceeding group (e.g. focus group inter-
view questions and components of the osteoporosis tool
design were modified and refined for transcripts of sub-
sequent focus groups) until themes were saturated.
Results
The characteristics of 16 participants (12 family physi-
cians, 3 general internists, and 1 rheumatologist) from
4 focus groups are in Table 1. Seventy-five percent of
participants were family physicians and men, and practi-
cing for > 25 years (44%), in mostly urban or inner city
centres (56%). Most physicians (87%) practiced in a
private office or clinic setting, and were in a group or
Table 1 Characteristics of focus group participants
(N = 16)*
Characteristic N (%)
Gender
Men 12 (75)
Women 4 (25)
Age range (years)
25-35 2 (12)
36-45 4 (25)
46-55 2 (12)
56-65 6 (37)
> 65 2 (12)
Type of physician
Family 12 (75)
General Internal Medicine 3 (19)
Other specialist: Rheumatology 1 (6)
Years in practice (years)
< 5 1 (6)
5-10 2 (12)
11-15 3 (19)
16-25 3 (19)
> 25 7 (44)
Type of practice
Group 7 (44)
Solo 4 (25)
Academic 2 (12)
Combination 3 (19)
Practice setting
Private office/clinic 14 (87)
Academic centre 3 (19)
Practice location
Urban 9 (56)
Inner city 6 (37)
Suburban 1 (6)
Using an EHR or CPOE
EHR (range of integration: partial to 99%) 6 (37)
CPOE (range of integration: < 10% to 100%) 5 (31)
*EHR = electronic health record; CPOE = computerized provider order entry.
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(56%). Of the proportion of participants who utilized an
electronic health record (EHR) or computer physician
order entry (CPOE) system in their practice (31-37%),
the range of integration of these systems varied widely
(< 10% to 100%). The TPI score indicated that 87% of
participants had a positive attitude toward computers
and the Internet (average TPI score 3.8) (Table 2).
We identified 3 broad categories of themes: 1) Partici-
pants’ perception and understanding of the meaning and
use of CDSSs; 2) Participants’ identification of problems
with the RAQ component of the osteoporosis tool, and
suggestions for modifying specific questions; and 3) The
facilitators and barriers to using the 3 components of
the tool.
1) Perception and understanding the meaning, and the
use of CDSSs
We identified 5 themes from participants’ description of
CDSSs:
Theme 1: The perception and understanding of the
meaning of CDSSs
Participants understood the meaning of CDSSs as a
“device or system or program or guideline that takes
them down a pathway that helps to decide on an appro-
priate decision given certain parameters of patients”.
Most described it as “a tool where you can plug in
data”, “an algorithm that can be used in a computer sys-
tem”, or a tool that “asks for patient data and provides
case-specific advice on how to proceed”. Some partici-
pants described CDSSs in the context of risk assessment
at the point of care: “For me a clinical decision support
tool would be for example a test, a rapid screening test
that helps us to make a quick diagnosis so you can treat
it on the spot...”. Most participants expressed that
CDSSs should work consistently, be evidence-based, and
provide a level of standardization to every day practice.
Theme 2: Format, characteristics, and features of CDSSs
Participants described CDSSs within a paper-based con-
text such as laminated cards and questionnaires with
“tick boxes”,b u tm o s tt h o u g h tt h a tt h ef o r m a ts h o u l d
be computer-based using a handheld device or a Tablet
PC. Several participants described the use of a flow-
chart-based system such as the “Framingham” cardiovas-
cular risk assessment tool [30], which was frequently
cited as an example to describe CDSS. Positive features
of CDSSs were described as quick to use, user-friendly
(simple, clear, easy to use), accessible (portable, small),
and inexpensive. Negative features were described as
confusing, cumbersome or difficult to use, and not
accessible or portable.
Theme 3: Components to include, and data processing and
navigation of CDSSs
Participants suggested that CDSSs should include
reminders for appropriate diagnosis and treatment,
major and minor risk factors, a 10-year fracture risk
graph, lab tests, an option for disease management stra-
tegies, and a search box for evidence-based information.
Most thought that CDSSs should be algorithm and evi-
dence-based, problem centered, and be able to generate
something that can be printed and given to patients.
Having too many choices, or layered links or pathways
were identified as barriers to use: “Id o n ’tw a n tt og o
through 12 different layers before I finally get to things.”
Theme 4: When and where to use CDSSs
Most participants indicated that they would use a CDSS
at the point of care, but only if the system did not take
too much time to use: “If it is going to be something that
takes 10 minutes to go through from start to finish then
it takes too much time.” Suggestions were to use CDSS
during a physical examination appointment or following
the patient visit if the problem was too complex, and to
administer the RAQ component of the tool in the
reception area or examination rooms if patients were
involved in completing the questionnaire. However, they
pointed out that barriers in some settings might be the
lack of space in exam rooms or lack of confidentiality in
the reception area.
Theme 5: Preparation before a patient visit
Most participants do not have time to prepare before a
patient visit and have little time between visits (range
between 10 seconds to a few minutes). Most described
their preparation for a visit as reviewing patient charts
while walking the patient to the examination room or
reviewing the chart in front of the patient during the
visit. Assistance from nurses or clinic staff in the form
of notes and reminders on the chart (e.g. the reason for
the visit, if the visit is a physical appointment, things to
do for the next visit, abnormal lab or radiology results,
and other results of completed tests) was identified as a
major facilitator for preparation before patient visits.
2) Problems with the Risk Assessment Questionnaire
(RAQ), and suggestions for modifying questions
Participants identified problems with 7 of the 13 ques-
tions in the RAQ, of which 4 questions required the
Table 2 Participants’ attitudes toward computers and the
Internet (N = 15)*
Technology Profile Inventory (TPI) Factor Average TPI score†
Interest 3.6
Approval 4.5
Confidence 3.6
Average TPI score across all factors 3.8
*Adapted from Spence I, DeYoung CG, and Feng J. The Technology profile
inventory: Construction, validation, and application Computers in Human
Behaviour 2009, 25(2):458-465. †Score is based on a 5-point Likert scale where
1 = strongly disagree, 3 = neutral, 5 = strongly agree.
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participants thought that clinic staff would not have
time to answer the question about BMD test results (i.e.
to extract T-scores) (Figure 4). Additionally, they were
concerned that extracting and recording T-scores
requires interpretive skills and thus training, which
could further burden time and available resources: “I
don’t think pulling BMD test results from patient charts
will happen in our setting...I mean no one has time to do
that... also should the admin person be looking at the
results, unless they knew what to look at, and how would
they interpret it?”. Although the extractability of BMD
test results was important for the design of the RAQ
because T-scores can be used to predict osteoporosis
and fracture risk [31], this question was consequently
modified to redirect the question to patients, but to
probe only for information on whether or not they have
ever had a BMD test, and if yes, whether it was done
within or over 2 years ago.
Second, participants disagreed with the wording of the
caffeine and alcohol questions (Figure 5) because they
believed that patients would not respond honestly:
“Patients lie to you. You have to ask the question in a
different way so they don’t get threatened”.T h e ya l s o
thought that the term: “drinking in excess” may be con-
fusing for patients. Participants suggested providing a
wider selection of response options consisting of varying
amounts of alcohol or caffeine consumed (or none), and
to ask the question in terms of weekly rather than daily
consumption for alcohol. Other suggestions were to
provide definitions and pictures for alcohol and caffeine
units.
Third, participants were concerned that patients might
not recognize or understand “osteopenia” or may be
confused about the term: “rheumatoid arthritis” in the
question probing for conditions (Figure 6). Participants
suggested rephrasing the question to: “have you ever
been told by a physician that you have one of these con-
ditions?” because “chances are they don’t have the condi-
tion if they never heard of it.”
In the fourth question requiring extensive modifica-
tions, participants thoughtt h a ti tw a sag o o di d e at o
show pictures of medications (Figure 7), but did not
think that patients would recognize pictures of pills.
They also identified several other osteoporosis medica-
tions that should be added to the list such etidronate
(e.g. Didrocal®) and anti-seizure medications to the list
such as phenytoin (e.g. Dilantin®) and carbamazepine
(e.g. Tegretol®). Other suggestions were to represent the
medications in categories, and to ensure that the list is
continuously updated as guidelines change.
3) Facilitators and barriers to using the 3 components of
the osteoporosis tool (ie, the RAQ, BestPROMPT and
COPE)
Component 1: Risk Assessment Questionnaire (RAQ)
Participants were concerned about confidentiality and
possible damage to the Tablet PCs if patients completed
the RAQ in the waiting room/reception area. Sugges-
tions to overcome these problems were to complete the
questionnaire in the examination rooms, which would
provide more security for the Tablet PCs and more priv-
acy for patients. Others suggested that an appointment
dedicated to osteoporosis or a physical examination visit
Figure 4 RAQ question about bone mineral density testing.
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RAQ. Participants were also concerned that patients
might not understand the RAQ questions or provide
inaccurate responses, particularly elderly patients or
those with limited or no computer experience. Sugges-
tions for improving the RAQ were to organize the ques-
t i o n si nt h eo r d e ro fr i s kf a c t o r sa so u t l i n e di n
guidelines, to include a “Warning” if patients missed a
question, and to add an introduction about osteoporosis
at the beginning of the questionnaire.
Component 2: Best practice recommendation prompt
(BestPROMPT) for physicians
Participants liked the BestPROMPT output, and consid-
ered the section outlining the major and minor risk factors
for osteoporosis as the most helpful. Identified barriers
were related to content and usability of the BestPROMPT.
For example, many participants were not familiar with or
did not find the osteoporosis risk assessment instrument
(ORAI, which can help identify women who should have a
BMD test) [32] as a value-added feature for determining
who should receive a BMD test. Suggestions for improving
the BestPROMPT were to add a section on “lifestyle” such
as physical activity, smoking, and diet as part of the sug-
gested treatment recommendations, and to provide some-
thing “visual” such as a 10-year risk graph to help patients
conceptualize their fracture risk.
Most participants indicated that they would use the
sheet in front of their patient at the point of care, but
Figure 5 RAQ question about alcohol consumption.
Figure 6 RAQ question about medications.
Kastner et al. BMC Medical Informatics and Decision Making 2010, 10:40
http://www.biomedcentral.com/1472-6947/10/40
Page 9 of 15also pointed out that lack of time could be the largest
barrier: “You see 50 people a day, so even if it takes a
minute, that is another hour a day. I don’t want to stay
another hour just to screen for osteoporosis”.A l t h o u g h
physicians understood the benefits of the BestPROMPT,
they did not think it was feasible to generate the sheet
for every patient or every visit.
Component 3: Customized osteoporosis education (COPE)
for patients
Participants believed that the COPE sheet would provide
useful information to patients about osteoporosis: “It
would be a very strong tool for somebody to come out of
an office with a thing saying my risk factors are this and
my diagnosis is this and I am supposed to do this. That
would be very, very powerful.” However, participants
emphasized that the wording of the COPE sheet needs
to be more balanced so that patients don’ts t o pt a k i n g
important medications for other conditions that are
associated with osteoporosis risk: “You’ve got to be very
careful with what you say in the patient printout. You’re
actually saying that if you’re taking prednisone this will
harm your bone density. Then she’s going to stop predni-
sone and her asthma is going to become terrible. So, you
have to be very careful in what you say to patients
because you don’t want them to stop taking their asthma
medication.”
Other suggestions were to increase the print size, and
to include statements that encourage patients to discuss
the suggested treatment recommendations with their
physician.
Discussion
Our study revealed physicians’ understanding of CDSSs
in the context of what they would find useful in their
own practice. The progressive analysis and iterative
focus group structure was useful for identifying the spe-
cific features and functions that physicians perceived as
important to include in CDSSs–to be computer-based,
user-friendly, to enhance workflow, and to be accessible
at the point of care. The finding that “lack of time” was
perceived as the largest barrier to using CDSSs is not
surprising, as this has been shown consistently in pre-
vious studies [33-35], and hence should be an important
consideration when designing CDSSs. The time burdens
on physicians just before and during a clinical encounter
confirmed our decision to design the tool to target the
completion of the RAQ to patients. Potential solutions
to meet this challenge include ensuring that the risk
assessment component of the tool could be used with-
out assistance and within a short period of time (e.g.
5 minutes) by the target patient population (i.e. men ≥
65 years of age and postmenopausal women), and that
the physician component of the tool was also quick to
use, clear, and concise. Our study also revealed the spe-
cific facilitators and barriers to the use of each of the 3
components of the conceptual osteoporosis tool. These
findings were useful for informing the transformation of
the conceptual design of the osteoporosis into a func-
tional prototype, but can also be relevant to the devel-
opment of other, similar tools. Please see Figures 8, 9,
10 for screenshots of the evolution of the 3 components
of the osteoporosis tool from conceptual design to post-
focus group prototype.
During our exploration of themes, several important
challenges emerged, which will be considered when the
prototype is further refined in usability and evaluation
studies. Evidence indicates that CDSSs can be pro-
grammed within EHR systems, have the potential to
Figure 7 RAQ question about conditions.
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patient-specific decision support at the point of care,
and improve guideline adherence [36-38]. The concep-
tual model of our osteoporosis tool was designed with
this type of integration so that risk assessment data
could be directly extracted from the EHR. This was
important in our design because the time it takes to use
the tool can be greatly reduced if fewer pieces of
information are entered into the RAQ. The integration
between CDSSs and EHRs also facilitates the compo-
nents of clinical decision support (for physicians) or
delivery of education (for patients) to be available at the
point of care. However, in the US and Canada, this type
of integration may be a challenge for several reasons.
First, the adoption of EHR systems overall remains
low at less than 30% in North America [39-41]
Figure 8 Screen shots of the evolution of selected Risk Assessment Questionnaire (RAQ).
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Page 11 of 15Figure 9 Screen shot of the evolution of the Best Practice Recommendation Prompt (BestPROMPT) sheet.
Figure 10 Screen shot of the evolution of the Customized Osteoporosis Education (COPE) sheet).
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tralia, Norway, and the UK that report EHR adoption
rates of up to 60-90% [42]. The current study found
usage was slightly above the US and Canada rates (31-
37%), but the level of EHR integration varied widely
(< 10% to 100%). These results are consistent with a
recent national survey in the US, which showed that
only 4% of survey respondents were fully integrated with
a nE H Rs y s t e ma n do n l y1 3 %u s e dab a s i cs y s t e m[ 4 0 ] .
This implies that adoption does not guarantee that phy-
sicians will use EHRs for all practice functions.
Second, there are an overwhelming number of EHR
vendors available in the US (> 250) and Canada (>45)
[43,44]. These systems vary widely in features and cap-
abilities, most are independently owned, and most use
proprietary non-standards-based integration interfaces,
which makes integration with other software difficult
[45]. Wide-scale implementation of CDSSs would then
be a challenge, even if EHR systems were in place,
because the vendors differ in their protocols and stan-
dards for accepting third-party software programming.
The slow progress toward the development of interoper-
able systems also contributes to the problem [46,47].
Although the inability to integrate CDSSs with EHR sys-
tems may diminish their potential [37], this does not
decrease their potential value for improving outcomes–
CDSSs can still be developed and used as standalone
systems to positively impact clinical practice.
Our data also revealed that workflow differences and
the role of customization are important factors that
need to be considered during the tool design process.
Although workflow analysis techniques are often used
prior to implementing hospital health information sys-
tems, they have largely been neglected in small practice
settings even though this is where the majority of
patient care is provided [48]. A systematic review of
CDSSs found that only 13% of trials evaluated the
impact of the CDSS on clinician workflow [37]. The
lack of workflow analysis in small physician practices
may also in part explain low EHR and CDSS adoption
rates and tool implementation failures. When asked to
comment on the conceptual design of the tool during
the focus group sessions, the conflicting barriers and
facilitators that were identified for the osteoporosis tool
c l e a r l ye x p o s e dt h ec o m p l e x i t yo ff a m i l yp h y s i c i a n s ’
practice settings and their widely differing practice
workflows. For example, the success of the point-of-care
feature of the osteoporosis tool (i.e., the delivery of the
BestPROMPT sheet for physicians just before they see
their patients) is directly dependent on the processes
that are used by individual physicians to prepare for a
patient visit. In the focus group study, this ranged from
taking a few minutes to look at the EHR, to reviewing a
paper chart on the way to the examination room. This
practice variability has major implications on the
intended function of the tool to deliver practice recom-
mendations at the point of care. To meet the specific
needs of physicians, customization of information tech-
nology systems such as the osteoporosis tool may be
needed by matching and supporting the desired work-
flow [48].
Limitations
There are a number of limitations to our study that are
related to the inherent challenges to conducting qualita-
tive studies. We attempted to minimize selection bias by
randomly selecting participants from a homogeneous
group of physicians for the pilot focus group. However,
it was not possible to continue random selection for
subsequent focus groups because the response rates
were low so we adjusted our sampling strategy to be
purposive. Although generalizability may have been
affected, it is possible to “transfer” findings to other
environments by taking into consideration how well
they fit with the current study’s methods, procedures,
and audience [27].
Another potential limitation was that we did not plan
focus groups with patients at risk for osteoporosis. As
this focus group study represented the early stages of
the tool development process, patients were excluded
because it was important to first understand the CDSS
needs of physicians and how the conceptual osteoporo-
sis tool might fit into their practice and workflow. We
planned a priori, to use this information to then inform
the level of involvement that would be needed by
patients for the development of the risk assessment
component of the tool.
We addressed other potential threats to validity by
pilot testing the focus group questions to ensure that
they were well understood, and to use an experienced
moderator to lead focus group discussions. To limit
potential biases that may be introduced by investigators,
we standardized procedures, methods, and analysis stra-
tegies across all 4 focus groups. Sessions were planned
so that physicians were prompted about their percep-
tions of CDSSs before introducing the conceptual design
of the osteoporosis tool. Lastly, we sent participants a
summary report of the focus group sessions at the end
of the study to provide an opportunity to verify the con-
tent of the discussions.
Next steps
Using study findings and consultation with information
technologists and human factors engineers, the concep-
tual design of the tool was transformed into a working
prototype. Evaluation of the prototype will begin with
usability testing of the tool on all end users (i.e. physi-
cians and patients) using the method described by
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an important step to avoid problems and errors, which
can occur if the needs of end users are not considered
as part of the tool development process [50]. Once the
osteoporosis tool is further refined during usability eva-
luation, the prototype will be implemented in 3 family
practice settings and pilot tested in an evaluation study.
Conclusions
Findings from our progressive focus groups were used
to develop a functional prototype that may aid physi-
cians in their clinical decision making in osteoporosis
disease management at the point of care. The prototype
incorporates all aspects of disease management (risk
assessment, diagnosis, and treatment), and is multi-tar-
geted to deliver clinical decision support for physicians
and education for patients about osteoporosis.
Additional material
Additional file 1: Focus group interview guide. Semi-structured
questions that was used in the focus groups with physicians.
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